Minerva Urologica E Nefrologica最新文献

{"title":"Four dilation techniques in percutaneous nephrolithotomy: a single-institute comparative analysis.","authors":"F. Chiancone, C. Meccariello, M. Fedelini, R. Giannella, P. Fedelini","doi":"10.23736/S0393-2249.20.03836-9","DOIUrl":"https://doi.org/10.23736/S0393-2249.20.03836-9","url":null,"abstract":"BACKGROUND\u0000The aim of this study was to compare four renal access techniques in percutaneous nephrolithotomy (PCNL).\u0000\u0000\u0000METHODS\u0000A total of 437 patients who underwent PCNL at our Center from January 2015 to December 2019 were included in the analysis. Telescopic metallic coaxial dilation (TMD) was usedin 146 patients, single step balloon dilation (BD) in 98 patients, one-shot dilation with 30 F Amplatz (OS 30F) in 106 patients, and one-shot dilation with 16 F Amplatz (OS 6F) in 87 patients. Primary endpoints were perioperative outcomes and complications of the procedures.\u0000\u0000\u0000RESULTS\u0000Similar baseline characteristics were observed in the four groups. Fluoroscopy time was significantly shorter in OS 30F and OS 16 F groups (p<0.0001). The drop in haemoglobin level was not significantly different between TMD and BD groups but it was significantly lower in OS 16F group versus the OS 30F group and lower in OS 30F group versus the BD Group (p<0.0001). Despite this, the rate of blood transfusion was similar across groups (p=0.837). Moreover, a smaller tract was associated with reduced postoperative morbidity including time to nephrostomy removal (p=0.001), hospital stay (p<0.0001), VAS scale (p<0.0001). There were no significant differences in postoperative complications (p=0.683), and Clavien-Dindo grade ≥3 complication rates (p=0,486) among the groups. Stone-free rates and number of auxiliary procedures required to achieve stone-free status were also similar among all groups (p=0.964 and 0.988, respectively). Multinomial logistic regression analysis showed that BMI (p=0.002), stone size (p=0.002) and previous PCNL (p=0.038) were predictive factors associated with the choice of OS 16 approach.\u0000\u0000\u0000CONCLUSIONS\u0000Different dilation methods are equally effective and safe to use in a PCNL procedurefor kidney stone treatment, allowing similar stone free rates and risk of complications. The OS dilation techniques seem to allow a shorter X-ray exposure time, which might be beneficial for both patients and operators. The use of a 16F dilator can reduce the postoperative morbidity. Risk of sepsis should be always kept in mind.","PeriodicalId":49015,"journal":{"name":"Minerva Urologica E Nefrologica","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89935691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Artifacts and abnormal findings may limit the use of asymptomatic volunteers as controls for studies of multi-channel urodynamics.","authors":"N. Swavely, J. Speich, A. Klausner","doi":"10.23736/S0393-2249.20.03838-2","DOIUrl":"https://doi.org/10.23736/S0393-2249.20.03838-2","url":null,"abstract":"BACKGROUND\u0000Multi-channel urodynamics is the gold-standard for the evaluation of LUTS. When performing studies to validate new adjuncts to urodynamic testing with control patients undergoing urodynamic investigation there is difficulty in interpretation of urodynamic results in the asymptomatic patient due to artifacts and the invasive nature of the procedure. The purpose of this investigation was to examine urodynamics in asymptomatic volunteers in order to better understand the role of control participants in urodynamic research studies.\u0000\u0000\u0000METHODS\u0000Asymptomatic volunteers with no LUTS were recruited to undergo standard urodynamic testing as a comparison group in a study evaluating novel urodynamic techniques. To be eligible, participants had to report no LUTS, score ≤1 on all symptom questions of the ICIq-OAB survey, have no medical conditions or be on any medications that affect bladder function. The urodynamics was done according to ICS standards. All tracings were evaluated by an expert neuro-urologist. Data were analyzed categorically for the presence or absence of low compliance (< 30ml/cmH20), detrusor overactivity, bladder outlet obstruction (BOOI > 40), weak contractility (BCI < 100), straining to void, poorly sustained detrusor contraction, uncoordinated EMG activity, and intermittent flow.\u0000\u0000\u0000RESULTS\u0000A total of 24 participants completed the study including 10 men and 14 women. All participants had at least 1 urodynamic abnormality/artifact with an average of 4.43±1.28 abnormalities/participant. The most common abnormalities included uncoordinated EMG activity (87.50%), straining to void (79.17%), and intermittent flow (70.83%). There were no significant differences for sex, age, BMI.\u0000\u0000\u0000CONCLUSIONS\u0000This study demonstrated that healthy, asymptomatic volunteers have high rates of abnormal urodynamic findings, suggesting that asymptomatic participants are not the ideal controls in research studies that involve urodynamic testing.","PeriodicalId":49015,"journal":{"name":"Minerva Urologica E Nefrologica","volume":"38 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81205762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Urologic surgery in a safe hospital during the COVID-19 pandemic scenario.","authors":"R. Papalia, R. Cataldo, R. Alloni, K. Pang, A. Alcini, G. Flammia, Annamaria Salerno, M. Notarangelo, S. Angeletti, A. Venditti, L. Sommella, R. Scarpa, F. Esperto","doi":"10.23736/S0393-2249.20.03923-5","DOIUrl":"https://doi.org/10.23736/S0393-2249.20.03923-5","url":null,"abstract":"The COVID-19 pandemic induced a global emergency that overwhelmed most hospitals around the world. Access to Hospitals has been restricted to selective oncological and urgent patients to minimize surgeries requiring Intensive Care Unit care. All other kind of non- urgent and benign surgeries have been rescheduled. The burden of oncological and urgent cases on the healthcare system has increased. We have been asked to become the referral center for major oncological and urgent urological surgeries, increasing our surgical volume. Through meticulous hospital protocols on PPE, use of nasopharyngeal swabs, controlled hospital access and the prompt management of suspected/positive cases, we were able to perform 31% more urological surgical procedures during the COVID-19 pandemic compared to the same period in 2019. We observed a 72% increase in oncological surgical procedures and 150% in urgent procedures. Our experience shows how the management of oncological and urgent cases can be maintained during unexpected, global emergencies, such as COVID-19.","PeriodicalId":49015,"journal":{"name":"Minerva Urologica E Nefrologica","volume":"99 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76984135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Bipolar plasmakinetic transurethral enucleation and resection versus bipolar plasmakinetic transurethral resection for surgically treating large (≥ 60 g) prostates: a propensity score-matched analysis with a 3-year follow-up.","authors":"Wen Deng, Luyao Chen, Xiaoqiang Liu, Hao Jiang, Zhengtao Zhou, Yulei Li, Gongxian Wang, B. Fu","doi":"10.23736/S0393-2249.20.03804-7","DOIUrl":"https://doi.org/10.23736/S0393-2249.20.03804-7","url":null,"abstract":"BACKGROUND\u0000There are extremely limited published studies comparing bipolar plasmakinetic transurethral resection of prostate (BP-TURP) and bipolar plasmakinetic transurethral enucleation and resection of prostate (BP-TUERP) for enlarged prostates. Our purpose is to evaluate the safety and efficiency of BP-TUERP and BP-TURP for large (≥ 60 g) prostates with a 3-year follow-up.\u0000\u0000\u0000METHODS\u0000We retrospectively identified 229 patients according to inclusion criteria between 2014 and 2016. After applying propensity score matching method, preoperative results and three-year follow-up outcomes in International Prostate Symptom Score (IPSS), urinary peek flow rate (Qmax), postvoid residual urine (PVRU) volume and quality of life (QoL) score were compared.\u0000\u0000\u0000RESULTS\u0000Finally, within the well-balanced matched cohort, the BP-TUERP was significantly associated with longer mean operating time (OT) (p = 0.039), shorter mean catheter time (CT) (p = 0.001) and lower mean hemoglobin decrease (p = 0.002) with more prostatic tissue removed (p = 0.001) than the BP-TURP, but the median hospital stay lengths and the short- and long-term complication rates were similar between the two series. The patients in the BP-TUERP group had better long-term outcomes in IPSS, Qmax and PVRU volume than these in the BP-TURP group, but not in QoL score.\u0000\u0000\u0000CONCLUSIONS\u0000For patients with large (≥ 60 g) prostates, BP-TUERP and BP-TURP are safe options, but the former is a more effective choice in long-term follow-up outcomes. BP-TUERP is related to reduced CT and hemoglobin decrease with more removal of prostatic tissue at the expense of longer OT than BP-TURP.","PeriodicalId":49015,"journal":{"name":"Minerva Urologica E Nefrologica","volume":"11 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81044412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"PSMA PET/CT and staging high risk prostate cancer: a non-systematic review of high clinical impact literature.","authors":"J. J. Morigi, Jack Anderson, C. de Nunzio, S. Fanti","doi":"10.23736/S0393-2249.20.03739-X","DOIUrl":"https://doi.org/10.23736/S0393-2249.20.03739-X","url":null,"abstract":"INTRODUCTION\u0000Prostate specific membrane antigen (PSMA) positron emission tomography (PET) with computed tomography (CT) is a promising molecular imaging technique for prostate cancer (PCa). Although not yet included in international guidelines, PSMA PET/CT is commonly used in clinical practice to stage patients with newly diagnosed PCa. This review focuses on the most up-to-date literature on staging high risk prostate cancer with PSMA PET/CT.\u0000\u0000\u0000METHODS\u0000An online based literature research encompassing original studies, reviews and meta-analysis was performed in the month of November of 2019. The most relevant and impactful research was then extracted based on the expertise of the authors, with the specific focus of highlighting the clinical impact and appropriateness of PSMA PET/CT in staging PCa.\u0000\u0000\u0000RESULTS\u0000The use of PSMA PET/CT is appropriate in all high-risk patients with newly diagnosed PCa as it will often have a significant clinical impact. Although preliminary findings are promising, there is still a scarcity of data regarding the performance of PSMA PET/CT vs other modalities in defining disease within the prostate gland. There is good evidence suggesting that PSMA PET/CT may be superior to every other imaging modality in assessing loco-regional and distant metastatic disease.\u0000\u0000\u0000CONCLUSIONS\u0000PSMA PET/CT has the potential to become a gold standard in staging high risk prostate cancer, providing clinicians with accurate information on the extent of disease within the prostate and the presence of loco-regional and distant metastatic disease within a single scan.","PeriodicalId":49015,"journal":{"name":"Minerva Urologica E Nefrologica","volume":"35 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76893983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A systematic review of imaging-guided metastasis-directed therapy for oligorecurrent prostate cancer: revolution or devolution?","authors":"Simone Albisinni,&nbsp;Julien Van Damme,&nbsp;Fouad Aoun,&nbsp;George Bou Kheir,&nbsp;Thierry Roumeguère,&nbsp;Cosimo De Nunzio","doi":"10.23736/S0393-2249.20.03675-9","DOIUrl":"https://doi.org/10.23736/S0393-2249.20.03675-9","url":null,"abstract":"<p><strong>Introduction: </strong>Metastasis directed therapy (MDT) is increasingly being implemented in recurring prostate cancer (PCa), although its role in PCa management has yet been fully defined. Aim of the current systematic review is to analyze current knowledge of MDT in the setting of recurrent PCa and highlight future trials which will continue to shed a light on a controversial aspect of current PCa management.</p><p><strong>Evidence acquisition: </strong>The National Library of Medicine Database was searched for relevant articles published between January 2014 and August 2019. A wide search was performed including the combination of following words: ([metastasis AND directed AND therapy] AND prostate AND cancer). The selection procedure followed the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) principles.</p><p><strong>Evidence synthesis: </strong>Biologic studies support the use of MDT in oligometastatic PCa. Modern imaging techniques as PSMA PET/CT, Fuciclovine PET/CT and whole-body MRI are fundamental to implement such an approach given the high diagnostic yield at low PSA values. The majority of data available on MDT concerns retrospective trials, although three prospective randomized trials (STOMP, ORIOLE and POPSTAR) have assessed the safety and feasibility of MDT. Overall, it appears that MDT delays significantly PCa progression and time to systemic therapy.</p><p><strong>Conclusions: </strong>MDT is highly appealing given its potential to delay disease progression and adverse events of systemic therapy. Nonetheless, data remains immature to recommend MDT on a large scale and the selection criteria for patients have yet been defined. Today, MDT should be administered within a clinical trial and results of future research are eagerly awaited.</p>","PeriodicalId":49015,"journal":{"name":"Minerva Urologica E Nefrologica","volume":"72 3","pages":"279-291"},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37664088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Is urodynamic evaluation able to change and improve the management of women with idiopathic overactive bladder?","authors":"M. Serati, Simona Cantaluppi, A. C. Coluccia, Chiara Scancarello, C. Cimmino, A. Braga, S. Salvatore, E. Finazzi Agró, F. Ghezzi","doi":"10.23736/S0393-2249.20.03801-1","DOIUrl":"https://doi.org/10.23736/S0393-2249.20.03801-1","url":null,"abstract":"BACKGROUND For women with overactive bladder (OAB), current guidelines recommend the use of urodynamic studies (UDS) only in complicated cases. This study aimed to investigate whether UDS can also be helpful in uncomplicated cases. Specific aims of the study were (a): to evaluate objective benefit and subjective patient satisfaction with tailored treatment based on the UDS diagnosis compared to the outcomes of the pharmacological treatment only based on the symptoms; (b) to investigate the correlation between symptoms and UDS findings in women with uncomplicated idiopathic OAB symptoms; (c) to assess the ability of UDS to modify management decisions in these patients. METHODS Women presenting to our clinic with a history of uncomplicated OAB symptoms for the past three months or more, and who completed the International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF), were considered for this study. We proposed UDS to all participants. In women who accepted UDS (group 1), management decisions were made on the basis of urodynamic findings and post-treatment evaluation was scheduled at three months. The outcomes of treatments in these patients were compared to the results in women who did not accept UDS and who received pharmacological treatment symptoms-based (group 2). Objective outcomes were based on completion of a 3-day micturition diary. Subjective outcomes were captured using the Overactive Bladder Questionnaire Short Form (OABq-SF), the Patient Global Impression of Improvement (PGI-I) scale, and a patient satisfaction scale. RESULTS A total of 680 women were enrolled in the study; 478 underwent UDS and 202, at the contrary, declined UDS. In 53.6% of cases, UDS led to modification of the proposed management approach. At the 3- month follow-up, the overall patient satisfaction rate in group 1 and group 2 was 77 % and 65.8%, respectively (p=0.003). CONCLUSIONS we showed that OAB management tailored according to the UDS diagnosis results in higher subjective satisfaction if compared with a pharmacological treatment symptoms-based. Our study confirmed a lack of correlation between OAB symptoms and the urodynamically proven diagnosis of detrusor overactivity (DO). It also suggested that UDS can determine the underlying pathophysiology of every woman with OAB syndrome, whether complicated or uncomplicated, allowing treatment to be appropriately tailored with better results.","PeriodicalId":49015,"journal":{"name":"Minerva Urologica E Nefrologica","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88636805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Assessment of local tumor ablation and non-interventional management versus partial nephrectomy in T1a renal cell carcinoma.","authors":"C. Palumbo, F. Mistretta, S. Knipper, E. Mazzone, A. Pecoraro, Z. Tian, P. Perrotte, A. Antonelli, F. Montorsi, S. Shariat, F. Saad, C. Simeone, A. Briganti, L. Lavallée, P. Karakiewicz","doi":"10.23736/S0393-2249.19.03496-9","DOIUrl":"https://doi.org/10.23736/S0393-2249.19.03496-9","url":null,"abstract":"BACKGROUND\u0000Local tumor ablation (LTA) and non-interventional management (NIM) emerged as alternative management options for T1a renal cell carcinoma (RCC). We investigated trends and cancer-specific mortality (CSM) after LTA and NIM, compared to partial nephrectomy (PN).\u0000\u0000\u0000METHODS\u0000Within the Surveillance, Epidemiology, and End Results database (2004-2015), T1a RCC patients treated with PN, LTA or NIM were identified. Estimated annual proportion change methodology (EAPC), 1:1 ratio propensity score (PS) matching, cumulative incidence plots and multivariable competing risks regression models (CRR) were used to compare LTA vs PN and NIM vs PN. Subgroup analyses focused on patients <65 and ≥65years.\u0000\u0000\u0000RESULTS\u0000Overall 4,524 patients underwent LTA vs 1,654 NIM vs 25,435 PN. Annuals rates increased for NIM (EAPC: +3.3%, p<0.001), but not for either LTA or PN. After PS-matching in multivariable CCR, LTA (HR 1.9, p<0.001) and NIM (HR 3.0, p<0.001) showed worse 5-year CSM, relative to PN. In subgroup analyses, LTA showed no CSM disadvantage relative to PN in younger patients (HR 2.0, p=0.07). In older patients 1.64-fold CSM increase was recorded. Conversely, NIM younger (HR 3.1, p=0.001) and older (HR 3.1, p<0.001) patients exhibited higher CSM relative to PN.\u0000\u0000\u0000CONCLUSIONS\u0000In T1a RCC patients, NIM rates showed a modest but significant increase, while LTA and PN rates remained stable. In survival analyses, LTA exhibited higher CSM rates only for elderly patients. Conversely, NIM exhibited higher CSM rates in both younger and older patients.","PeriodicalId":49015,"journal":{"name":"Minerva Urologica E Nefrologica","volume":"2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90207216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Interest and involvement of European urology residents in academic and research activities. An ESRU-ESU-ESUT collaborative study.","authors":"Diego M Carrion,&nbsp;Moises E Rodríguez-Socarrás,&nbsp;Guglielmo Mantica,&nbsp;Karl H Pang,&nbsp;Francesco Esperto,&nbsp;Angelika Mattigk,&nbsp;Diederick Duijvesz,&nbsp;Juan L Vásquez,&nbsp;Jesús Díez Sebastián,&nbsp;Roberto M Scarpa,&nbsp;Rocco Papalia,&nbsp;Joan Palou,&nbsp;Juan Gómez Rivas","doi":"10.23736/S0393-2249.20.03734-0","DOIUrl":"https://doi.org/10.23736/S0393-2249.20.03734-0","url":null,"abstract":"","PeriodicalId":49015,"journal":{"name":"Minerva Urologica E Nefrologica","volume":"72 3","pages":"384-387"},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37744679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical pathways for urology patients during the COVID-19 pandemic.","authors":"Alchiede Simonato,&nbsp;Gianluca Giannarini,&nbsp;Alberto Abrate,&nbsp;Riccardo Bartoletti,&nbsp;Alessandro Crestani,&nbsp;Cosimo De Nunzio,&nbsp;Andrea Gregori,&nbsp;Giovanni Liguori,&nbsp;Giacomo Novara,&nbsp;Nicola Pavan,&nbsp;Carlo Trombetta,&nbsp;Andrea Tubaro,&nbsp;Francesco Porpiglia,&nbsp;Vincenzo Ficarra","doi":"10.23736/S0393-2249.20.03861-8","DOIUrl":"https://doi.org/10.23736/S0393-2249.20.03861-8","url":null,"abstract":"<p><p>The public health emergency caused by the Coronavirus Disease 2019 (COVID-19) pandemic has resulted in a significant reallocation of health resources with a consequent reorganization of the clinical activities also in several urological centers. A panel of Italian urologists has agreed on a set of recommendations on pathways of pre-, intra- and post-operative care for urological patients undergoing urgent procedures or non-deferrable oncological interventions during the COVID-19 pandemic. Simplification of the diagnostic and staging pathway has to be prioritized in order to reduce hospital visits and consequently the risk of contagion. In absence of strict uniform regulations that impose the implementation of nasopharyngeal swabs, we recommend that an accurate triage for COVID-19 symptoms be performed both by telephone at home before hospitalization and at the time of hospitalization. We recommend that during hospital stay patients should be provided with as many instructions as possible to facilitate their return to, and stay at, home. Patients should be discharged under stable good conditions in order to minimize the risk of readmission. It is advisable to reduce or reschedule post-discharge controls and implement an adequate system of communication for telemonitoring discharged patients.</p>","PeriodicalId":49015,"journal":{"name":"Minerva Urologica E Nefrologica","volume":"72 3","pages":"376-383"},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37782074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}